
First doses of AstraZeneca vaccine have been delivered to Ghana – statement
24 February 2021 22:24
|


JOHANNESBURG (HORN OBSERVER) First doses of the AstraZeneca vaccine have been delivered to Ghana through COVAX, according to a statement released by Pascal Soriot, Chief Executive Officer at AstraZeneca on Wednesday.
The delivery is the first of many shipments of the AstraZeneca vaccine.
"I am delighted that the first doses of the AstraZeneca vaccine have been delivered to Ghana today through COVAX. This marks a major step forward in changing the course of the pandemic globally,” Soriot said on behalf of AstraZeneca, the global science-led biopharmaceutical company.
"From the start, we have committed to making our vaccine available to as many countries as possible and at no profit during the pandemic because no-one is safe until everyone is safe.”
AstraZeneca says many shipments of vaccine are expected over the coming weeks and months via COVAX that will take closer to ensuring broad and equitable access.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Leave a comment
- Popular
- Rated
- Commented
04/11/2021 - 11:05:02
28/05/2024 - 15:44:10
02/12/2021 - 11:34:53
01/11/2022 - 22:25:50
01/03/2021 - 09:00:37
Opinions
02/04/2025 - 18:34:53
27/02/2025 - 20:18:23
Politics
03/03/2025 - 11:25:20
02/03/2025 - 01:13:33
Terror Watch
02/04/2025 - 18:34:53
30/03/2025 - 16:22:23
Press Releases
03/04/2025 - 00:16:33
02/04/2025 - 16:48:19
30/03/2025 - 16:22:23
First doses of AstraZeneca vaccine have been delivered to Ghana – statement
JOHANNESBURG (HORN OBSERVER) First doses of the AstraZeneca vaccine have been delivered to Ghana through COVAX, according to a statement released by Pascal Soriot, Chief Executive Officer at AstraZeneca on Wednesday.